Metric Finance
LearnFAQ
LearnFAQ

Learn / IRON

NASDAQ: IRON

Disc Medicine (IRON) stock, explained like you're 5

Disc Medicine trades on the Nasdaq under the ticker IRON. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.4 billion dollars.

Ticker
IRON
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 2.4 billion dollars

Is Disc Medicine a small, medium or large cap company?

No. Disc Medicine is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Disc Medicine makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves IRON stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Disc Medicine (NASDAQ:IRON) Stock Gets Downgrade from Wall Street Zen (MarketBeat)
  • Disc Medicine (Nasdaq:IRON) Stock Analysis (Simply Wall Street)
  • Labrador Iron Ore Royalty Corporation (LIF.TO) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Here’s How Much You Would Have Made Owning Iron Mountain Stock In The Last 5 Years (Benzinga)
  • Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns (Stocktwits)

Follow IRON in your daily brief

Each trading day at 5 PM ET we post what happened to Disc Medicine and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow IRON

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Disc Medicine stock

What does Disc Medicine do?

Disc Medicine trades on the Nasdaq under the ticker IRON. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.4 billion dollars.

What is the ticker symbol for Disc Medicine?

Disc Medicine trades under the ticker IRON on the Nasdaq.

What is Disc Medicine's market cap?

Disc Medicine is a mid cap stock with a market cap of about 2.4 billion dollars.

How does Disc Medicine make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves IRON stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow IRON stock every day?

Add IRON to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow IRON daily

A free brief on Disc Medicine and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare IRON: IRON vs NVS, IRON vs AZN, IRON vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed